Role of Iron in Alcoholic Liver Disease
Sponsored by: National Institute on Alcohol Abuse and Alcoholism
and the
Office of Dietary Supplements
Friday, October 25, 2002
Hyatt Regency, Bethesda, MD
Organizer:
Vishnudutt Purohit, Ph.D.
Program Director
Biomedical Research Branch/Division of Basic Research
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
6000 Executive Boulevard/ suite 402
Bethesda, M.D., 20892-7003
Phone: (301) 443-2689; Fax: (301) 594-0673
E-mail: vpurohit@willco.niaaa.nih.gov
Agenda:
| 7:45 - 8:30 |
Breakfast
|
| 8:30 - 8:40 |
Opening Remarks
Sam Zakhari, Ph.D., NIAAA/NIH
Paul Coates, Ph.D., ODS/NIH
|
| 8:40 - 9:00 |
Introduction to the Symposium
Vishnudutt Purohit, Ph.D., NIAAA/NIH
Christine Swanson, Ph.D., ODS/NIH
|
| Morning Session:
|
Chairperson: Bin Gao, M.D., Ph.D., NIAAA/NIH
|
| 9:00 - 9:40 |
An Overview of Iron Metabolism
Tracy Rouault, M.D., NICHD/NIH
|
| 9:40 - 10:20 |
Iron-Dependent Macrophage Cell Activation in Alcoholic Liver Disease
Hidekazu Tsukamoto, D.V.M., Ph.D., University of Southern California
|
| 10:20 - 10:50 |
Break
|
| 10:50 - 11:30 |
Iron and CYP2E1-Induced Oxidative Stress in Alcoholic Liver Disease
Arthur I. Cederbaum, Ph.D., Mount Sinai School of Medicine, New York
|
| 11:30 - 12:10 |
Iron-Induced Oxidant Stress and Liver Fibrogenesis
Antonello Pietrangelo, M.D., Ph.D., University of Modena and Reggio Emilia, Italy
|
| 12:10 - 1:15 |
Lunch
|
| Afternoon Session:
|
Chairperson: Denise Russo, Ph.D., NIAAA/NIH
|
| 1:15 - 1:55 |
Hemochromatosis and Alcoholic Liver Disease
Lawrie W. Powell, M.D., Ph.D., The Queensland Institute of Medical Research, Australia
|
| 1:55 - 2:35 |
Iron in non-Hemochromatic Liver Diseases
Herbert Bonkovsky, M.D., University of Connecticut Health Center, Connecticut
|
| 2:35 - 3:00 |
Break
|
| 3:00 - 3:40 |
Iron and Cancer
Yves Deugnier, M.D., Service des Maladies du Foie CHU Pontchaillou, France
|
| 3:40 - 4:20 |
Iron Chelators and Iron Toxicity
Gary M. Brittenham, M.D., Columbia University, New York
|
| 4:20 - 5:20 |
Discussion
David Brenner, M.D., University of North Carolina at Chapel Hill
Patricia Greenwel, Ph.D., CSR/NIH
|
|
|
